top of page

Scientific studies on mRNA

Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccine

Purpura Annularis Telangiectodes

Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis an analysis of cases notified to the European Medicines Agency

Cerebral venøs trombose

Fatal Post COVID mRNA-Vaccine Associated Cerebral Ischemia

Cerebral venøs trombose

Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccin

Cerebral venøs trombose

COVID-19 Vaccine-Associated Cerebral Venous Thrombosis in Germany

Cerebral venøs trombose

Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults

Cerebral venøs trombose

Cerebral venous thrombosis post BNT162b2 mRNA SARS-CoV-2 vaccination A black swan event

Cerebral venøs trombose

Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine

Cerebral venøs trombose

Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine

Cerebral venøs trombose

Central Venous Sinus Thrombosis with Subarachnoid Hemorrhage Following an mRNA COVID-19 Vaccination Are These Reports Merely Co-Incidental

Cerebral venøs trombose

A Risk Factor for Cerebral Thrombotic Syndromes

Cerebral venøs trombose

Unexpected vaginal bleeding and COVID-19 vaccination in nonmenstruating women

Reproductive Issues

Transplacental transmission of the COVID-19 vaccine messenger RNA, evidence from placental, maternal, and cord blood analyses postvaccination

Reproductive Issues

Transplacental transmission of the COVID-19 vaccine messenger RNA, evidence from placental, maternal, and cord blood analyses postvaccinatio

Reproductive Issues

Skewed fate and hematopoiesis of CD34+ HSPCs

Reproductive Issues

Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy.pdf

Reproductive Issues

Premenstrual and menstrual changes reported after COVID-19 vaccination, The EVA project.pdf

Reproductive Issues

Neutralizing Activity and SARS-CoV-2 Vaccine mRNA Persistence in Serum and Breastmilk After BNT162b2 Vaccination in Lactating Women

Reproductive Issues

Menstrual cycle disturbances after COVID-19 vaccination

Reproductive Issues

Japanese Pfizer biodistribution studies translated, SARS-CoV-2 mRNA Vaccine (BNT162, PF-07302048) 2.6.4 Summary statement of the pharmacokinetic study

Reproductive Issues
bottom of page